KCF advised DMS Group on the carve-out and reverse IPO of its medical imaging division

January 2022

KCF acted as exclusive financial advisor to DMS Group in connection with the carve-out and reverse IPO of its medical imaging division on Euronext Brussels via the acquisition of Asit Biotech.

With more than 30 years of experience, DMS Imaging is a leading French player in medical imaging diagnostics, with the ambition to become a leading partner of the world’s largest MedTech companies.